ArticleMolecular biomedicine2025

Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progression.

Haoran Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.